Holocene Advisors, LP Intercept Pharmaceuticals, Inc. Transaction History

Holocene Advisors, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$39.09 - $53.44 $239,582 - $327,533	-6,129 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $286,224 - $564,113	6,129 New	6,129 $294,000
Q2 2018 Aug 14, 2018	SELL	$60.0 - $85.67 $242,280 - $345,935	-4,038 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $304,194 - $388,032	-5,770 Reduced 58.83%	4,038 $248,000
Q4 2017 Feb 14, 2018	BUY	$58.2 - $72.76 $570,825 - $713,630	9,808	9,808 $573,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.